Dr. Pablo A Catangay, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1205 Rio Vista Dr, Mahwah, NJ 07430 Phone: 201-684-1217 |
News Archive
A gene known as FTO, which appears to be correlated with obesity in humans, may also increase risk of Alzheimer's disease and dementia, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, HI. And when a person has certain variants of both FTO and a recognized Alzheimer's risk gene known as APOE, the risk of Alzheimer's could be doubled.
APCER Pharma, the truly global provider of outsourced services for clinical safety, pharmacovigilance, medical affairs, and regulatory operations, announced that the company's Managing Director, Dr. Vineet Kacker, will be one of the leaders in a workshop on developing a successful global Medical Affairs strategy.
HHS Secretary Kathleen Sebelius has announced $320 million in grants under the Affordable Care Act (ACA) to strengthen the health care workforce. Of those grants, $253 million will go to improve and expand the primary care workforce under the Prevention and Public Health Fund of the Affordable Care Act.
The advantages of prescribing angiotensin-converting enzyme (ACE) inhibitors for stable coronary artery disease (CAD) may be increased by targeting the therapy to the patients most likely to benefit.Clinical characteristics alone do not allow a reliable identification of these patients, so a research programme was carried out at Erasmus University Medical Centre in Rotterdam to develop a genetic profiling model that predicts the treatment benefits of ACE inhibitors and optimises the recommended therapy.
› Verified 6 days ago